Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

RxSight (RXST) EBT Margin (2020 - 2025)

RxSight (RXST) has disclosed EBT Margin for 6 consecutive years, with 91.17% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT Margin rose 10591.0% year-over-year to 91.17%, compared with a TTM value of 0.0% through Dec 2025, up 1959.0%, and an annual FY2025 reading of 0.0%, up 1959.0% over the prior year.
  • EBT Margin was 91.17% for Q4 2025 at RxSight, up from 32.32% in the prior quarter.
  • Across five years, EBT Margin topped out at 91.17% in Q4 2025 and bottomed at 275.15% in Q2 2021.
  • Average EBT Margin over 5 years is 87.95%, with a median of 61.04% recorded in 2023.
  • Peak annual rise in EBT Margin hit 19943bps in 2021, while the deepest fall reached -195394bps in 2021.
  • Year by year, EBT Margin stood at 186.87% in 2021, then soared by 48bps to 97.02% in 2022, then skyrocketed by 67bps to 32.18% in 2023, then skyrocketed by 54bps to 14.74% in 2024, then surged by 719bps to 91.17% in 2025.
  • Business Quant data shows EBT Margin for RXST at 91.17% in Q4 2025, 32.32% in Q3 2025, and 34.94% in Q2 2025.